The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 18, 2008

Filed:

Dec. 26, 2002
Applicants:

Debashish Datta, Pune, IN;

Muralikrishna Dantu, Pune, IN;

Brijkishore Mishra, Pune, IN;

Pollepeddi Lakshmi Narayana Sharma, Pune, IN;

Inventors:
Assignee:

Lupin Limited, Maharashtra, IN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 501/22 (2006.01); C07D 501/24 (2006.01); C07D 501/36 (2006.01); C07D 501/46 (2006.01); C07D 501/34 (2006.01); C07C 305/14 (2006.01);
U.S. Cl.
CPC ...
Abstract

A novel 4-halo-2-oxyimino-3-oxo butyric acid-N,N-dimethyl formiminium chloride chlorosulfate of formula (I) useful in the preparation of cephalosporin antibiotics wherein X is chlorine or bromine; R is hydrogen, Calkyl group, an easily removable hydroxyl protective group, —CHCOOR, or —C(CH)COOR, wherein Ris hydrogen or an easily hydrolysable ester group. The compound of formula (I) is prepared by reacting 4-halo-2-oxyimino-3-oxobutyric acid of formula (IV), wherein X, R and Rare as defined above, with N,N-dimethylformiminium chloride chlorosulphate of formula (VII) in an organic solvent at a temperature ranging from −30° C. to −15° C. The cephalosporins that may be prepared from the intermediate include cefdinir, cefditoren pivoxil, cefepime, cefetamet pivoxil, cefixime, cefmenoxime, cefodizime, cefoselis, cefotaxime, cefpirome, cefpodoxime proxetil, cefquinome, ceftazidime, cefteram pivoxil, ceftiofur, ceftizoxime, ceftriaxone and cefuzonam.


Find Patent Forward Citations

Loading…